Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.79 USD | -1.10% | 0.00% | -5.26% |
Apr. 18 | Verastem Names John Hayslip as Chief Medical Officer | MT |
Apr. 15 | I-Mab Announces Chief Medical Officer Changes | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.26% | 146M | |
+24.17% | 562B | |
-6.21% | 358B | |
+19.19% | 322B | |
+7.71% | 297B | |
+13.45% | 219B | |
+6.04% | 199B | |
-10.51% | 196B | |
-11.73% | 149B | |
-6.23% | 146B |
- Stock Market
- Equities
- IMAB Stock
- News I-Mab
- I Mab : to Move Forward With Chinese Trial of Felzartamab in Systemic Lupus Erythematosus